Search results
Results: 297
Number of items: 297
-
Endres, A., Schaich, A., Arntz, A., Fassbinder, E., & Renner, F. (2025). A Journey Through Time - Study Protocol for a Randomized Controlled Trial Testing the Add-on Effects of Imagery Rescripting to Ongoing Cognitive Behavioural Therapy in Patients With Depressive Disorders. Clinical Psychology in Europe, 7(4), Article e16709. https://doi.org/10.32872/cpe.16709 -
Daniëls, M., Meewisse, M. L., Nugter, A., Rameckers, S. A., Fassbinder, E., & Arntz, A. (2025). Imagery Rescripting (ImRs) and Eye Movement Desensitization and Reprocessing (EMDR) as treatment of childhood-trauma related post-traumatic stress disorder (Ch-PTSD) in adults: effects on Schema Modes. European Journal of Psychotraumatology, 16, Article 2454191. https://doi.org/10.1080/20008066.2025.2454191 -
Kool, M., van den Eshof, H., Van, R., Dekker, J., Peen, J., & Arntz, A. (2025). Long-term dosage effects of psychodynamic and schema therapy in depressed patients with personality disorders: 18 and 24 months follow-up of a randomized controlled trial. Psychological Medicine, 55, Article e210. https://doi.org/10.1017/S0033291725101025 -
Mayer, P. L., Westermair, A. L., Assmann, N., Bloo, J., Calvo, N., De Panfilis, C., Fassbinder, E., Ferrer, M., Jacob, G., Richetin, J., Schaich, A., Preti, E., Klein, J. P., & Arntz, A. (2025). Psychometric Evaluation of the Borderline Personality Disorder Checklist. International Journal of Methods in Psychiatric Research, 34(3), Article e70029. https://doi.org/10.1002/mpr.70029 -
van Trigt, S., Mendoza-Alvarez, M., van der Zweerde, T., De Picker, L., van Straten, A., Arntz, A., & van Marle, H. J. F. (2025). Psychometric properties of the 4-week version of the Borderline Personality Disorder Severity Index-5. Comprehensive Psychiatry, 143, Article 152634. https://doi.org/10.1016/j.comppsych.2025.152634 -
Assmann, N., Kaiser, T., Herzog, P., Arntz, A., Klein, J. P., Fassbinder, E., & Schaich, A. (2025). Differential effectiveness of dialectical behavioural therapy and schema therapy in patients with borderline personality disorder: a secondary analysis of a randomised clinical trial. Behaviour Research and Therapy, 195, Article 104899. https://doi.org/10.1016/j.brat.2025.104899 -
Baljé, AE., Greeven, A., Deen, M., van Giezen, AE., Arntz, A., & Spinhoven, P. (2025). Exploring Moderators and Mediators of the Outcome of Group Cognitive Behavioural Therapy Compared With Group Schema Therapy for Social Anxiety Disorder and Comorbid Avoidant Personality Disorder. Clinical Psychology and Psychotherapy, 32(5), Article e70148. https://doi.org/10.1002/cpp.70148 -
Lortye, S., Will, J. P., Marquenie, L. A., Lommerse, N. M., Faber, N., Goudriaan, A. E., Arntz, A., & de Waal, M. M. (2025). Effectiveness of treating post-traumatic stress disorder in patients with co-occurring substance use disorder with prolonged exposure, eye movement desensitization and reprocessing or imagery rescripting: A randomized controlled trial. Addiction, 120(11), 2231-2244. https://doi.org/10.1111/add.70097 -
Setkowski, K., Arntz, A., & Cuijpers, P. (2025). Reply to Choi-Kain and colleagues’: Correspondence to Setkowski and colleagues on best psychotherapies for borderline personality disorder. Psychological Medicine, 55, Article e41. https://doi.org/10.1017/S0033291724002708 -
Assmann, N., Jacob, G., Schaich, A., Berger, T., Zindler, T., Betz, L., Borgwardt, S., Arntz, A., Fassbinder, E., & Klein, J. P. (2025). A digital therapeutic for people with borderline personality disorder in Germany (EPADIP-BPD): a pragmatic, assessor-blind, parallel-group, randomised controlled trial. The Lancet Psychiatry, 12(5), 366-376. https://doi.org/10.1016/S2215-0366(25)00063-X
Page 2 of 30